1. Home
  2. SNGX vs ILAG Comparison

SNGX vs ILAG Comparison

Compare SNGX & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

N/A

Current Price

$2.96

Market Cap

7.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
SNGX
ILAG
Founded
1987
1981
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
7.2M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
SNGX
ILAG
Price
$0.37
$2.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
205.9K
803.0
Earning Date
05-08-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.27
52 Week High
$2.98
$7.19

Technical Indicators

Market Signals
Indicator
SNGX
ILAG
Relative Strength Index (RSI) 40.30 43.02
Support Level $0.36 $2.06
Resistance Level $0.42 $3.82
Average True Range (ATR) 0.02 0.15
MACD -0.00 -0.00
Stochastic Oscillator 7.46 32.93

Price Performance

Historical Comparison
SNGX
ILAG

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Taiwan.

Share on Social Networks: